CHURCHILL CAPITAL CORP IX (CCIX) Stock Fundamental Analysis

NASDAQ:CCIX • KYG213011094

10.64 USD
+0.01 (+0.09%)
Last: Feb 27, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Taking everything into account, CCIX scores 2 out of 10 in our fundamental rating. CCIX was compared to 0 industry peers in the Unkown industry. The financial health of CCIX is average, but there are quite some concerns on its profitability. CCIX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year CCIX was profitable.
  • In the past year CCIX has reported a negative cash flow from operations.
CCIX Yearly Net Income VS EBIT VS OCF VS FCFCCIX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 0 2M 4M 6M 8M

1.2 Ratios

Industry RankSector Rank
ROA 3.01%
ROE 3.11%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CCIX Yearly ROA, ROE, ROICCCIX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 -100 -200 -300

1.3 Margins

  • CCIX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CCIX Yearly Profit, Operating, Gross MarginsCCIX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • The number of shares outstanding for CCIX has been increased compared to 1 year ago.
  • CCIX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CCIX Yearly Shares OutstandingCCIX Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 10M 20M 30M
CCIX Yearly Total Debt VS Total AssetsCCIX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • CCIX has an Altman-Z score of 22.99. This indicates that CCIX is financially healthy and has little risk of bankruptcy at the moment.
  • CCIX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 22.99
ROIC/WACCN/A
WACCN/A
CCIX Yearly LT Debt VS Equity VS FCFCCIX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • CCIX has a Current Ratio of 5.79. This indicates that CCIX is financially healthy and has no problem in meeting its short term obligations.
  • A Quick Ratio of 5.79 indicates that CCIX has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 5.79
Quick Ratio 5.79
CCIX Yearly Current Assets VS Current LiabilitesCCIX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • CCIX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40066.67%, which is quite impressive.
EPS 1Y (TTM)40066.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-34.77%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 42.56, CCIX can be considered very expensive at the moment.
  • CCIX is valuated expensively when we compare the Price/Earnings ratio to 27.07, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 42.56
Fwd PE N/A
CCIX Price Earnings VS Forward Price EarningsCCIX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CCIX Per share dataCCIX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • CCIX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CHURCHILL CAPITAL CORP IX

NASDAQ:CCIX (2/27/2026, 8:00:02 PM)

10.64

+0.01 (+0.09%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)02-05
Earnings (Next)N/A
Inst Owners99.12%
Inst Owner Change3.49%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap390.06M
Revenue(TTM)N/A
Net Income(TTM)9.17M
AnalystsN/A
Price TargetN/A
Short Float %0.05%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 42.56
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.32
P/tB 1.32
EV/EBITDA N/A
EPS(TTM)0.25
EY2.35%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0
BVpS8.04
TBVpS8.04
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.73
Profitability
Industry RankSector Rank
ROA 3.01%
ROE 3.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.79
Quick Ratio 5.79
Altman-Z 22.99
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40066.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-34.77%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-4272.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

CHURCHILL CAPITAL CORP IX / CCIX FAQ

What is the fundamental rating for CCIX stock?

ChartMill assigns a fundamental rating of 2 / 10 to CCIX.


What is the valuation status for CCIX stock?

ChartMill assigns a valuation rating of 0 / 10 to CHURCHILL CAPITAL CORP IX (CCIX). This can be considered as Overvalued.


How profitable is CHURCHILL CAPITAL CORP IX (CCIX) stock?

CHURCHILL CAPITAL CORP IX (CCIX) has a profitability rating of 0 / 10.


Can you provide the PE and PB ratios for CCIX stock?

The Price/Earnings (PE) ratio for CHURCHILL CAPITAL CORP IX (CCIX) is 42.56 and the Price/Book (PB) ratio is 1.32.